CG Oncology (CGON) Leases (2023 - 2025)
CG Oncology (CGON) has disclosed Leases for 3 consecutive years, with $4.0 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Leases rose 1696.83% year-over-year to $4.0 million, compared with a TTM value of $4.0 million through Dec 2025, up 1696.83%, and an annual FY2025 reading of $4.0 million, up 1696.83% over the prior year.
- Leases was $4.0 million for Q4 2025 at CG Oncology, down from $4.2 million in the prior quarter.
- Across five years, Leases topped out at $4.2 million in Q3 2025 and bottomed at $221000.0 in Q4 2024.
- Average Leases over 3 years is $1.3 million, with a median of $422000.0 recorded in 2023.
- The sharpest move saw Leases crashed 47.63% in 2024, then soared 1696.83% in 2025.
- Year by year, Leases stood at $422000.0 in 2023, then plummeted by 47.63% to $221000.0 in 2024, then skyrocketed by 1696.83% to $4.0 million in 2025.
- Business Quant data shows Leases for CGON at $4.0 million in Q4 2025, $4.2 million in Q3 2025, and $965000.0 in Q2 2025.